<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lopez-Sampere Y</submitter><funding>Carlos III Health Institute</funding><funding>Fundación Ramón Areces</funding><funding>Xarxa de Bancs de Tumors de Catalunya</funding><pagination>104068</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12907107</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>91</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Nuclear factor erythroid 2-related factor 2 (NRF2) regulates antioxidant defenses and protects against neurodegeneration, including Alzheimer's disease (AD). Its age-related decline disrupts redox balance and increases neuronal vulnerability, but the early hippocampal effects remain unclear. Here, we tested whether NRF2 loss affects tau seeding and spreading in a PHF-tau-inoculated mouse model, contributing to accelerated aging.&lt;h4>Methodology&lt;/h4>Three-month-old NRF2-knockout (Nfe2l2&lt;sup&gt;-/-&lt;/sup>) and wild-type (WT) mice received hippocampal inoculations of human AD-derived PHF-tau, and tau propagation was analyzed after three months. To elucidate the molecular underpinnings of the observed changes, we performed integrative phosphoproteotranscriptomic analyses of hippo</pubmed_abstract><journal>Redox biology</journal><pubmed_title>NRF2 deficit prevents pathologic Tau seeding and spreading in an induced tauopathy mouse model.</pubmed_title><pmcid>PMC12907107</pmcid><funding_grant_id>PT20/00171</funding_grant_id><funding_grant_id>PI23/00176</funding_grant_id><funding_grant_id>CD23/00097</funding_grant_id><funding_grant_id>PI20/000155</funding_grant_id><pubmed_authors>Vinyals A</pubmed_authors><pubmed_authors>Dakterzada F</pubmed_authors><pubmed_authors>Del Rio JA</pubmed_authors><pubmed_authors>Roca-Pereira S</pubmed_authors><pubmed_authors>Santamaria E</pubmed_authors><pubmed_authors>Romero L</pubmed_authors><pubmed_authors>Vela-Martinez M</pubmed_authors><pubmed_authors>Portero-Otin M</pubmed_authors><pubmed_authors>Andres-Benito P</pubmed_authors><pubmed_authors>Pinol-Ripoll G</pubmed_authors><pubmed_authors>Mato-Blanco X</pubmed_authors><pubmed_authors>Ferrer I</pubmed_authors><pubmed_authors>Fernandez-Irigoyen J</pubmed_authors><pubmed_authors>Santpere G</pubmed_authors><pubmed_authors>Povedano M</pubmed_authors><pubmed_authors>Mengod Soler P</pubmed_authors><pubmed_authors>Lopez-Sampere Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>NRF2 deficit prevents pathologic Tau seeding and spreading in an induced tauopathy mouse model.</name><description>&lt;h4>Background&lt;/h4>Nuclear factor erythroid 2-related factor 2 (NRF2) regulates antioxidant defenses and protects against neurodegeneration, including Alzheimer's disease (AD). Its age-related decline disrupts redox balance and increases neuronal vulnerability, but the early hippocampal effects remain unclear. Here, we tested whether NRF2 loss affects tau seeding and spreading in a PHF-tau-inoculated mouse model, contributing to accelerated aging.&lt;h4>Methodology&lt;/h4>Three-month-old NRF2-knockout (Nfe2l2&lt;sup&gt;-/-&lt;/sup>) and wild-type (WT) mice received hippocampal inoculations of human AD-derived PHF-tau, and tau propagation was analyzed after three months. To elucidate the molecular underpinnings of the observed changes, we performed integrative phosphoproteotranscriptomic analyses of hippo</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-15T21:30:11.849Z</modification><creation>2026-07-09T10:13:58.831Z</creation></dates><accession>S-EPMC12907107</accession><cross_references><pubmed>41650822</pubmed><doi>10.1016/j.redox.2026.104068</doi></cross_references></HashMap>